QA: Rezolute Inc. in us_pharma/2020

Table of Contents

See also this year's filing and all EDGAR filings for this company.

PDF Report 0001509261_2021_Rezolute_Inc.pdf

Logs

warning Missing logo subcommand.report {}
info Failed to set obs_EconomicCapitalRatio industry.us_generic {'reason': "KeyError('0001509261')"}

Graph

Absolute values for 0001509261, Rezolute Inc.

  xvar xval
0 AssetsCurrent 10,518,000
1 IntangibleAssetsNetIncludingGoodwill 0
2 PropertyPlantAndEquipmentNet 33,000
3 remainder_Assets 414,000
4 LiabilitiesCurrent 3,226,000
5 LiabilitiesNoncurrent 165,000
6 remainder_Liabilities 209,000
7 CostOfGoodsAndServicesSold 0
8 SellingGeneralAndAdministrativeExpense 6,071,000
9 ResearchAndDevelopmentExpense 14,450,000
10 remainder_Expenses 0
11 remainder_Revenues 0
12 remainder_NetIncome 188,000
13 remainder_ComprehensiveNetIncome 0
  yvar yval
0 Assets 10,965,000
1 Liabilities 3,600,000
2 Expenses 20,521,000
3 Revenues 0
4 StockholdersEquity 7,365,000
5 NetIncome -20,333,000
6 ComprehensiveNetIncome -20,333,000
7 BaseVar 17,637,000
8 EconomicCapitalRatio -1.05

Edgar->Model Mapping

Feature Distribution

Change over Time